Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.

Q3 Pharmacology, Toxicology and Pharmaceutics
Neuropsychopharmacologia Hungarica Pub Date : 2021-12-01
Judit Lazary, Laszlo Pogany, Carlos De Las Cuevas, G Alejandro Villasante-Tezanos, Jose De Leon
{"title":"Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.","authors":"Judit Lazary,&nbsp;Laszlo Pogany,&nbsp;Carlos De Las Cuevas,&nbsp;G Alejandro Villasante-Tezanos,&nbsp;Jose De Leon","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Findings of three articles reporting results in 1372 stabilized outpatients taking 2454 medications in Spain, Argentina, and Venezuela were combined. Prevalence of good adherence was not obviously different across diagnoses: 69.5% (N=212) for schizophrenia, 66.3% (N=142) for bipolar disorder, and 69.8% (N=521) for depression. Besides the focus on stabilized outpatients, other study biases included use of a research sample; limited to oral medications, ignoring long-acting injectable antipsychotics; and lack of data on active substance abuse, clinical severity, and insight. Logistic regression models explored predictors of good vs. poor adherence. The six self-reported variables studied were pharmacophobia, pharmacophilia, high psychological reactance, high internal health locus of control (LOC), high doctor LOC, and skepticism concerning specific medications. ORs were significant in 56% (47/84) of the statistical tests vs. 24% (23/98) of ORs significant in case of 7 demographic/clinical variables (p=0.001). At least 2/3 of the ORs for pharmacophobia, pharmacophilia and skepticism were significantly associated with adherence in cases and controls, indicating their independence from diagnoses. In need of replication, three other self-reported measures had differential effects on adherence across diagnoses. High psychological reactance was associated with decreased adherence to antidepressant medications in general, or for patients with mood disorders. High internal LOC as associated with poor adherence may reflect the distrust patients with schizophrenia or severe bipolar disorder have of other people. High doctor LOC was significantly associated with increased adherence only in patients with bipolar disorder, but was significant for all medications, mood stabilizers and antipsychotics, indicating the relevance of the patient-psychiatrist relationship in these patients. (Neuropsychopharmacol Hung 2021; 23(4): 363-373).</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"23 4","pages":"363-373"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychopharmacologia Hungarica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Findings of three articles reporting results in 1372 stabilized outpatients taking 2454 medications in Spain, Argentina, and Venezuela were combined. Prevalence of good adherence was not obviously different across diagnoses: 69.5% (N=212) for schizophrenia, 66.3% (N=142) for bipolar disorder, and 69.8% (N=521) for depression. Besides the focus on stabilized outpatients, other study biases included use of a research sample; limited to oral medications, ignoring long-acting injectable antipsychotics; and lack of data on active substance abuse, clinical severity, and insight. Logistic regression models explored predictors of good vs. poor adherence. The six self-reported variables studied were pharmacophobia, pharmacophilia, high psychological reactance, high internal health locus of control (LOC), high doctor LOC, and skepticism concerning specific medications. ORs were significant in 56% (47/84) of the statistical tests vs. 24% (23/98) of ORs significant in case of 7 demographic/clinical variables (p=0.001). At least 2/3 of the ORs for pharmacophobia, pharmacophilia and skepticism were significantly associated with adherence in cases and controls, indicating their independence from diagnoses. In need of replication, three other self-reported measures had differential effects on adherence across diagnoses. High psychological reactance was associated with decreased adherence to antidepressant medications in general, or for patients with mood disorders. High internal LOC as associated with poor adherence may reflect the distrust patients with schizophrenia or severe bipolar disorder have of other people. High doctor LOC was significantly associated with increased adherence only in patients with bipolar disorder, but was significant for all medications, mood stabilizers and antipsychotics, indicating the relevance of the patient-psychiatrist relationship in these patients. (Neuropsychopharmacol Hung 2021; 23(4): 363-373).

对精神药物的依从性:比较精神分裂症、双相情感障碍和重度抑郁症患者。
对西班牙、阿根廷和委内瑞拉的1372名稳定门诊患者服用2454种药物的三篇文章的结果进行综合分析。不同诊断的良好依从性患病率无明显差异:精神分裂症为69.5% (N=212),双相情感障碍为66.3% (N=142),抑郁症为69.8% (N=521)。除了关注稳定的门诊患者外,其他研究偏差包括使用研究样本;局限于口服药物,忽视长效注射抗精神病药物;缺乏药物滥用的数据,临床严重程度和洞察力。逻辑回归模型探讨了依从性好与依从性差的预测因素。研究的6个自我报告变量为药物恐惧症、药物偏好、高心理抗拒、高内在健康控制点(LOC)、高医生LOC和对特定药物的怀疑。在7个人口统计学/临床变量的情况下,56%(47/84)的统计学试验的or显著性高于24%(23/98)的or显著性(p=0.001)。在病例和对照组中,至少有2/3的药物恐惧症、药物偏好和怀疑的ORs与依从性显著相关,表明它们独立于诊断。需要重复的是,其他三种自我报告的测量方法对不同诊断的依从性有不同的影响。一般来说,高心理抗拒与抗抑郁药物依从性降低有关,或与情绪障碍患者有关。高内部LOC与较差的依从性相关,可能反映了精神分裂症或严重双相情感障碍患者对他人的不信任。高医生LOC仅与双相情感障碍患者的依从性增加显著相关,但对所有药物、情绪稳定剂和抗精神病药物均显著相关,表明这些患者的医患关系存在相关性。(《神经精神药物》2021;23(4): 363 - 373)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropsychopharmacologia Hungarica
Neuropsychopharmacologia Hungarica Medicine-Medicine (all)
CiteScore
1.60
自引率
0.00%
发文量
8
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信